Medical/Pharmaceuticals
Inmagene Exercises Option to Obtain Exclusive Worldwide License for IMG-007 and IMG-004 from HUTCHMED
* Inmagene exercised its option under the previously announced collaboration agreement to obtain an exclusive, royalty-bearing license for IMG-007, an anti-OX40 monoclonal antibody (mAb) and IMG-004, a Bruton Tyrosine Kinase (BTK) inhibitor * Inmagene retains rights to develop and commerciali...
2024-02-02 22:00
1485
World Cancer Day 2024: RemeGen Announces Three Significant Developments in the Global Fight Against Cancer, Narrowing the Care Gap
YANTAI, China, Feb. 2, 2024 /PRNewswire/ -- RemeGen Co. Ltd.
2024-02-02 21:30
1946
Results of Phase II Study on Qilu Pharmaceutical's Novel Drug QL1706 Published in Signal Transduction and Targeted Therapy
JINAN, China, Feb. 2, 2024 /PRNewswire/ -- On January 29th, the results of the phase II study on Qilu Pharmaceutical's novel anticancer drug iparomlimab and tuvonralimab (QL1706) were published online inSignal Transduction and Targeted Therapy (Impact Factor=39.3). The study investigated the use ...
2024-02-02 17:34
1527
Fapon and Bio Farma Sign MOU for Medical Innovations
DONGGUAN, China, Feb. 2, 2024 /PRNewswire/ -- On February 1, 2024, Fapon, a global leading life science company, andBio Farma, a state-owned pharmaceutical holding company inIndonesia specializing in vaccines, life science products, and other pharmaceuticals, signed a memorandum of understanding ...
2024-02-02 16:30
1786
Xinhua Silk Road: Pien Tze Huang, Beijing Tong Ren Tang agree to boost bilateral cooperation, promote high-quality development of TCM
BEIJING, Feb. 2, 2024 /PRNewswire/ -- Zhangzhou Pien Tze Huang Pharmaceutical
Co., Ltd. (Pien Tze Huang) signed a cooperation agreement with Beijing Tong Ren
Tang (TRT) Group during the First Conference of Partners of Tong Ren Tang,
which was held inBeijing from January 17 to 19.
2024-02-02 11:14
2202
NABR Files Expanded Petition Challenging the Listing of Long-Tailed Macaques by the IUCN
WASHINGTON, Feb. 2, 2024 /PRNewswire/ -- Working with recognized, independent scientists, the National Association for Biomedical Research (NABR) filed an expanded petition today with the International Union for Conservation of Nature (IUCN) challenging the designation of the long-tailed macaque ...
2024-02-02 09:01
1561
Biosyngen Announces FDA Fast Track Designation for BST02 in Treatment of Liver Cancer
SINGAPORE, Feb. 1, 2024 /PRNewswire/ -- Biosyngen is proud to announce that its latest groundbreaking product, BST02, has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA) for the treatment of all types of liver cancer, including hepatocellular carcinoma and...
2024-02-01 17:41
1705
EMA Aesthetics Announces a Long-Term Strategic and Equity Partnership with ROHTO Pharmaceutical, Signalling ROHTO's Acceleration into the Global Aesthetics Market
DUBLIN, Feb. 1, 2024 /PRNewswire/ --
EMA Aesthetics (www.emaaesthetics.com
2024-02-01 16:00
1756
NX Netherlands Receives IATA CEIV Pharma Certification for Its Warehouse Near Amsterdam Airport Schiphol
TOKYO, Feb. 1, 2024 /PRNewswire/ -- Nippon Express (Nederland) B.V. (hereinafter "NX Netherlands"), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired CEIV Pharma certification (*), a quality certification for pharmaceutical transport established by the International Air Transport As...
2024-02-01 14:00
1457
2024 Global Appeal Calls for Well-Informed Public to 'Break Chains of Discrimination' against Leprosy
TOKYO, Feb. 1, 2024 /PRNewswire/ -- Sasakawa Leprosy (Hansen's Disease) Initiative has partnered with the World Health Organization to co-host the launch of the 2024 Global Appeal to end stigma and discrimination against persons affected by leprosy at WHO headquarters inGeneva on January 31, 2024...
2024-02-01 14:00
1393
Promising Clinical Results on the World's First Use of BCMA CAR-T to Treat Immune Mediated Necrotizing Myopathy (IMNM) Published on the Proceedings of the National Academy of Sciences (PNAS)
SHANGHAI, NANJING, China and SAN JOSE, Calif., Jan. 31, 2024 /PRNewswire/ -- On Jan. 30, 2024, PNAS published the research paper titled "Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR T-cell therapy." The paper analyzed results using the fully human B ...
2024-02-01 11:07
1543
SoniVie announces enrollment completion in the REDUCED-1 pilot study with TIVUS™ Ultra-Sound Renal Denervation
SoniVie announces enrollment completion in the REDUCED-1 pilot study
TEL AVIV, Israel, Feb. 1, 2024 /PRNewswire/ -- SoniVie
2024-02-01 01:52
1382
Anbogen Secures 12.5 Million in Series A Funding, Advancing Precision Oncology Drug Development
TAIPEI, Jan. 31, 2024 /PRNewswire/ -- Anbogen Therapeutics, a clinical-stage biotechnology company specializing in groundbreaking cancer drug development, today announced the successful completion of its Series A funding round. The lead investor is China Development Industrial Bank (CDIB), with s...
2024-02-01 00:00
1314
Crystal Pharmatech's CDMO Business Unit - Crystal Formulations Services Successfully Passed EU QP Audit
SUZHOU, China, Jan. 31, 2024 /PRNewswire/ -- Recently, Crystal Formulations Services (CFS), the CDMO Business Unit of Crystal Pharmatech has achieved a significant milestone by successfully passing the on-site audit conducted by the European Qualified Person (QP), evaluating its GMP quality syste...
2024-01-31 21:00
1021
WuXi Biologics Successfully Completes First 1,6000L Manufacturing Run in Ireland
- First manufacturing run successful for MFG7 facility at the Ireland site - Largest manufacturing scale to date achieved by combining four 4,000-liter single-use bioreactors DUNDALK, Ireland, Jan. 31, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Researc...
2024-01-31 17:31
2139
IGIN: the first innovative device for automatic glove fitting, is now launching a pre-sale
DUBAI, UAE, Jan. 31, 2024 /PRNewswire/ -- Approximately 99,000 Americans die
each year in hospitals due to infections acquired there, according to the
Centres for Disease Control and Prevention (CDC). 3.5 million Europeans a year
contract an infection while in hospital.
IGIN Global
2024-01-31 17:13
1166
21ST.BIO OPENS A MORE SUSTAINABLE AVENUE FOR INDUSTRIAL SCALE DAIRY PROTEIN PRODUCTION
* Global bioproduction leader 21st.BIO today announced it is now granting access to its precision fermentation technology platform to food and ingredient manufacturers, enabling sustainable production of dairy proteins at competitive cost. * Access to 21st.BIO's technology represen...
2024-01-31 16:47
935
WuXi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development
SHANGHAI, Jan. 30, 2024 /PRNewswire/ -- WuXi XDC (2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of bioconjugate market; and Multitude Therapeutics, a clinical stage biotechnology company renowned for ADC platfor...
2024-01-31 10:43
2521
Synbio Tech's Innovative Probiotic Approach Revitalizes Gut and Vaginal Microbiota in Pregnant Women with Candidiasis
KAOHSIUNG, Jan. 31, 2024 /PRNewswire/ -- Innovative research and proprietary technologies have placed Synbio Tech, Inc. (1295:TT) at the forefront of the probiotics field. The company's advancements not only enhance probiotic production efficiency but also significantly benefit intestinal health,...
2024-01-31 09:00
1416
GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant
Starts undertaking quality evaluation and characterization of iPSCs in
accordance with ISO standards
PALO ALTO, Calif. , Jan. 30, 2024 /PRNewswire/ -- Leading GMP cell CDMO I
Peace, Inc. (https://www.ipeace.com
2024-01-31 05:46
1320
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 309 media titles]
2024-04-15 17:33
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 281 media titles]
2024-04-18 21:26
Animated Life in Yunnan
[Picked up by 278 media titles]
2024-04-18 14:00
Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
[Picked up by 276 media titles]
2024-04-15 08:00
Most Read
Sephora appoints Xia Ding as Managing Director of Sephora Greater China
2024-04-15 17:33
3814
Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
2024-04-15 08:00
3081
Goldpac Exhibits at InnoEx 2024
2024-04-13 10:00
2972
